Lupin has launched generic cancer drug Dasatinib Tablets, in multiple strengths, in the U.S. The product, bioequivalent to Bristol-Myers Squibb Company’s Sprycel Tablets, was developed by Lupin in ...
1h
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...
The Centers for Medicare & Medicaid Services just announced the next 15 brand-name medicines selected for Medicare’s drug price negotiation program, which mandates price reductions of at least 25%.
Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
12d
Ensuring Purity and Performance: The Rise of Top Pharmaceutical and Electrochemical Manufacturers
HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...
Nine-Point-Seven Percent CAGR Reflects Fundamental Industry Shift Toward Advanced LC-MS/MS and High-Resolution Platforms ...
The upgrade follows recent developments at Sentynl Therapeutics, a subsidiary of Zydus Lifesciences, which secured U.S. FDA ...
The Print on MSN
Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half
Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, examination or analysis.
The pharmaceutical industry operates under an uncompromising mandate: zero defects. Every tablet, capsule, vial, or syringe ...
Newsmax on MSN
Generics a commonsense answer to high drug prices
Generics a Commonsense Answer to High Drug Prices ...
VRC Medical Services, a specialty pharmaceutical distribution company supporting clinical research, announced recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results